Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations
1 other identifier
observational
60
1 country
1
Brief Summary
Eligible participants will be: benign thyroid nodules patients, to be involved in a consultation with their endocrinologist and/or surgeon and/or radiologist, in order to discuss treatment options related to benign thyroid nodules.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2022
CompletedFirst Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 2, 2024
March 1, 2024
2.8 years
March 26, 2024
March 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of predictive power of verbal synchrony established between patient and physician during the consultation on patients' satisfaction
The primary endpoint of our research is to test the predictive power of verbal synchrony established between patient and physician during the consultation on patients' satisfaction with tha analysis of audio and video recording file. Variables analyzed from audio recording will be use of words, verbal synchrony, empathic communication; variables analyzed from video recording will be facial emotion expression and facial emotion expression synchrony
1 month
Study Arms (1)
Benign thyroid nodules group
Participants with benign thyroid nodules involved in a consultation with endocrinologist and/or surgeon and/or radiologist, in order to discuss treatment options related to benign thyroid nodules
Eligibility Criteria
Patients with diagnosis of benign thyroid nodule with a scheduled consultation with endocrinologist and/or surgeon and/or radiologist to discuss treatment options related to benign thyroid nodule at European Institute of Oncology
You may qualify if:
- diagnosis of benign thyroid nodule;
- scheduled consultation with endocrinologist and/or surgeon and/or radiologist to discuss treatment options related to benign thyroid nodule;
- ≥18 years old at the time of recruitment;
- proper understanding of Italian language;
- fluent Italian speaker;
- able to comply to requested procedures to obtain audio-video recording.
- Each professional has to fulfill these criteria:
- proper understanding of Italian language;
- fluent Italian speaker;
- able to comply to requested procedures to obtain audio-video recording.
You may not qualify if:
- Patients with diagnosed mental or neurological disorder that could impair the participation will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
European Institute of Oncology
Milan, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriella Pravettoni
European Institute of Oncology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 2, 2024
Study Start
March 23, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 2, 2024
Record last verified: 2024-03